Group One Trading Portfolio holdings
AUM
$3.05B
1-Year Return
3.54%
This Quarter Return
+0.68%
1 Year Return
+3.54%
3 Year Return
+10.97%
5 Year Return
+15.65%
10 Year Return
+24.6%
AUM
$2.96B
AUM Growth
-$102M
(-3.3%)
Cap. Flow
-$84.7M
Cap. Flow
% of AUM
-2.86%
Top 10 Holdings %
Top 10 Hldgs %
22.57%
Holding
3,695
New
516
Increased
485
Reduced
755
Closed
616
Top Buys
| 1 |
Cigna
CI
|
+$165M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$57.2M |
| 4 |
Boeing
BA
|
+$39.7M |
| 5 |
ARK Innovation ETF
ARKK
|
+$25.7M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$88.6M |
| 2 |
Tesla
TSLA
|
+$83.2M |
| 3 |
Apple
AAPL
|
+$78.8M |
| 4 |
Advanced Micro Devices
AMD
|
+$46.7M |
| 5 |
Biogen
BIIB
|
+$28.9M |
Sector Composition
| 1 | Technology | 19.96% |
| 2 | Healthcare | 19.19% |
| 3 | Consumer Discretionary | 12.21% |
| 4 | Energy | 9.38% |
| 5 | Financials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Brookfield
BN
$101B
| $27.9K | ﹤0.01% |
887
-4,604
| -84% | -$145K |
|
|
OTRK
1227
DELISTED
Ontrak
OTRK
| $27.8K | ﹤0.01% |
842
-131
| -13% | -$4.33K |
|
|
BCLI
1228
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $27.8K | ﹤0.01% |
+1,132
| New | +$27.8K |
|
|
POL
1229
DELISTED
Polished.com Inc.
POL
| $27.8K | ﹤0.01% |
964
+298
| +45% | +$8.6K |
|
|
ADAP
1230
Adaptimmune Therapeutics
ADAP
$14.8M
| $27.8K | ﹤0.01% |
19,032
-2,000
| -10% | -$2.92K |
|
1231
Energous
WATT
$11.3M
| $27.7K | ﹤0.01% |
+55
| New | +$27.7K |
|
1232
Valley National Bancorp
VLY
$6.04B
| $27.7K | ﹤0.01% |
2,446
| – | – |
|
1233
Confluent
CFLT
$6.63B
| $27.6K | ﹤0.01% |
+1,243
| New | +$27.6K |
|
1234
Sphere 3D
ANY
$19.8M
| $27.5K | ﹤0.01% |
14,055
-2,460
| -15% | -$4.82K |
|
|
EMAN
1235
DELISTED
eMagin Corporation
EMAN
| $27.5K | ﹤0.01% |
32,385
-62,477
| -66% | -$53.1K |
|
1236
ESS Tech
GWH
$20.2M
| $27.5K | ﹤0.01% |
754
-1,485
| -66% | -$54.1K |
|
|
UROY
1237
Uranium Royalty Corp
UROY
$420M
| $27.2K | ﹤0.01% |
+11,492
| New | +$27.2K |
|
1238
Telus
TU
$24.3B
| $27.2K | ﹤0.01% |
+1,410
| New | +$27.2K |
|
1239
Radian Group
RDN
$4.76B
| $27.2K | ﹤0.01% |
1,425
-111
| -7% | -$2.12K |
|
1240
NETGEAR
NTGR
$831M
| $27K | ﹤0.01% |
1,492
-2,382
| -61% | -$43.1K |
|
1241
Newegg Commerce
NEGG
$901M
| $27K | ﹤0.01% |
1,030
-369
| -26% | -$9.67K |
|
1242
Ingredion
INGR
$8.09B
| $26.9K | ﹤0.01% |
+275
| New | +$26.9K |
|
1243
Fate Therapeutics
FATE
$111M
| $26.8K | ﹤0.01% |
2,654
+419
| +19% | +$4.23K |
|
|
AFMD
1244
DELISTED
Affimed
AFMD
| $26K | ﹤0.01% |
2,097
-8,714
| -81% | -$108K |
|
1245
Quince Therapeutics
QNCX
$85.9M
| $26K | ﹤0.01% |
40,745
-96,313
| -70% | -$61.4K |
|
1246
Nexa Resources
NEXA
$657M
| $25.9K | ﹤0.01% |
+4,293
| New | +$25.9K |
|
1247
TH International
THCH
$79.1M
| $25.5K | ﹤0.01% |
1,832
-1,506
| -45% | -$20.9K |
|
1248
Vital Farms
VITL
$2.17B
| $25.4K | ﹤0.01% |
+1,705
| New | +$25.4K |
|
|
UXIN
1249
Uxin Ltd
UXIN
$722M
| $25.4K | ﹤0.01% |
883
-1,519
| -63% | -$43.7K |
|
1250
Verastem
VSTM
$598M
| $25.4K | ﹤0.01% |
5,251
-3,789
| -42% | -$18.3K |
|